Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of remimazolam and dexmedetomidine in ERCP
ChiCTR2200057936Phase 4Not yet recruiting
- Sponsor
- Liaocheng City People's Hospital
- Start
- Feb 2022
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remimazolam, dexmedetomidine, propofol and fentanyl in None (3 arms), sponsored by Liaocheng City People's Hospital. Primary endpoint: Respiratory events. Planned start Feb 2022; status: not yet recruiting.
02
Drugs
remimazolamdexmedetomidinepropofolfentanyl
Beyond the preview
Go deeper on ChiCTR2200057936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200057936.